+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Weeks - 28Weeks
All Genders
ID05604846

Probiotic Supplementation to Reduce Necrotizing Enterocolitis and Mortality in Extremely Preterm Infants under 28 Weeks in Scandinavia

Led by Region Stockholm · Updated on 2023-10-16

1600

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether giving probiotics to extremely preterm infants born before 28 weeks of gestation can reduce the risk of necrotizing enterocolitis NEC, a serious intestinal disease, and neonatal death. This study is a double-blinded, randomized controlled trial involving 1620 extremely preterm infants at neonatal intensive care units in Sweden and Denmark. The goal is to provide evidence on the safety and effects of probiotic supplementation in this vulnerable group, which currently is not covered by clinical guidelines due to limited data. Infants who tolerate at least 3 mL of breastmilk per feeding will receive a daily probiotic supplement called ProPrems, which contains specific strains of beneficial bacteria mixed with breastmilk. This treatment will continue until the infant reaches 34 weeks of gestational age. The control group will receive breastmilk alone without the probiotic supplement. The study is carefully blinded so that medical staff and researchers do not know which infants receive probiotics, ensuring unbiased results. During the study, infants will be monitored for NEC and mortality up to 34 weeks gestational age plus 2 weeks, with secondary measures including sepsis, antibiotic use, hospital stay length, feeding tolerance, growth, and body composition after hospital discharge. Researchers will also collect stool samples to analyze gut microbiome development at multiple timepoints up to 12 months corrected age. Participation involves regular clinical assessments and data collection from medical records and neonatal quality registers, supporting a comprehensive evaluation of probiotic supplementation effects in extremely preterm infants.

CONDITIONS

Brief Title

Probiotic Supplementation in Extremely Preterm Infants in Scandinavia

Research Team

A

Alexander Rakow, MD PhD

S

Sofia Söderquist-Kruth

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here